Adam Kindelin Selected Research

complement C3a receptor

10/2022	Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.
12/2019	The Role of Complement C3a Receptor in Stroke.
4/2019	C3a Receptor Inhibition Protects Brain Endothelial Cells Against Oxygen-glucose Deprivation/Reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam Kindelin Research Topics

Disease

5	Stroke (Strokes) 01/2022 - 04/2019
4	Inflammation (Inflammations) 01/2021 - 12/2019
2	Cognitive Dysfunction 10/2022 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 10/2022 - 12/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 01/2020
1	Atrophy 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Neuroblastoma 01/2022
1	Disease Progression 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Optic Nerve Injuries 01/2021
1	Brain Infarction 01/2020
1	Infarction (Infarctions) 01/2020
1	Brain Injuries (Brain Injury) 12/2019
1	Ischemia 04/2019
1	Encephalitis (Encephalitis, Rasmussen) 04/2019

Drug/Important Bio-Agent (IBA)

3	complement C3a receptorIBA 10/2022 - 04/2019
3	Complement System Proteins (Complement)IBA 01/2021 - 04/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Oxygen (Dioxygen)IBA 01/2022 - 04/2019
2	SB 290157IBA 01/2020 - 04/2019
1	LipidsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2021
1	Complement C3a (Complement 3a)IBA 01/2021
1	Complement Inactivating AgentsIBA 01/2021
1	AnaphylatoxinsIBA 12/2019
1	AcidsIBA 12/2019

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2019
1	Lasers (Laser) 10/2022
1	Ischemic Postconditioning 01/2021